Mind Medicine (NASDAQ:MNMD) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.60) by 6.67 percent. This is a 6.67 percent increase over losses of $(0.60) per share from the same period last year.
Mind Medicine Q3 EPS $(0.56) Beats $(0.60) Estimate
Mind Medicine (NASDAQ:MNMD) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.60) by 6.67 percent. This is a 6.67 percent increase over losses of $(0.60) per share from the
Related Posts
Michael Saylor Asks ‘What Kind Of Bitcoiner Are You?’ Majority Say …
March 28, 6:22 AM
A recent tweet by MicroStrategy Inc. (NASDAQ: MSTR) founder Michael Saylor has created a conversation around Bitcoin (CRYPTO: BTC) investing.
Alnylam Presents 18-Month Results From The APOLLO-B Phase 3 Study Of Patisiran In Patients With ATTR Amyloidosis With Cardiomyopathy
May 20, 3:48 PM
– Continued Treatment with Patisiran in Open-Label Extension Period Showed Evidence of Sustained Benefit across Measures of Functional Capacity and Health Status and Quality of Life, as well as Cardiac Stress and Injury,
Summit Midstream Partners’s Earnings: A Preview
May 4, 2:02 PM
Summit Midstream Partners (NYSE:SMLP) is set to give its latest quarterly earnings report on Friday, 2023-05-05. Here’s what…